CagriSema, at least in its current clinical development program, targets a single maintenance dose of 2.4/2.4 mg, offering less room for individualization
How is DSIP Administered, and What is the Recommended Dosage
Individuals with Gastrointestinal Conditions: Certain gastrointestinal conditions, such as celiac disease, Crohns disease, or gastrointestinal surgery, can impair nutrient absorption
The patient can be positioned lying on their stomach or standing up
Can it be used without the matching wash products
Because they break down fast, detection windows are short compared to steroids or recreational drugs